406 related articles for article (PubMed ID: 30548306)
21. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
22. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
23. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
[TBL] [Abstract][Full Text] [Related]
24. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
Tang Q; Zheng X; Zhang J
Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
[TBL] [Abstract][Full Text] [Related]
27. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
28. TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma.
Liu K; Wu X; Zang X; Huang Z; Lin Z; Tan W; Wu X; Hu W; Li B; Zhang L
Oncol Res; 2017 Sep; 25(8):1329-1340. PubMed ID: 28256185
[TBL] [Abstract][Full Text] [Related]
29. LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway.
Wu JH; Tian XY; An QM; Guan XY; Hao CY
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1645-1652. PubMed ID: 29630107
[TBL] [Abstract][Full Text] [Related]
30. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
[TBL] [Abstract][Full Text] [Related]
31. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
32. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.
Sun L; Wang L; Chen T; Yao B; Wang Y; Li Q; Yang W; Liu Z
J Cell Mol Med; 2019 Dec; 23(12):8292-8304. PubMed ID: 31576658
[TBL] [Abstract][Full Text] [Related]
33. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
Zhang Z; Zhu J; Huang Y; Li W; Cheng H
Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
[TBL] [Abstract][Full Text] [Related]
34. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
Wang YG; Liu J; Shi M; Chen FX
J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
[TBL] [Abstract][Full Text] [Related]
35. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.
Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
Tumour Biol; 2014 Jun; 35(6):5189-98. PubMed ID: 24573607
[TBL] [Abstract][Full Text] [Related]
37. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway.
Ni Q; Chen Z; Zheng Q; Xie D; Li JJ; Cheng S; Ma X
Cancer Sci; 2020 May; 111(5):1500-1513. PubMed ID: 31997489
[TBL] [Abstract][Full Text] [Related]
38. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
[TBL] [Abstract][Full Text] [Related]
39. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
[TBL] [Abstract][Full Text] [Related]
40. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
